Clinical Research Directory
Browse clinical research sites, groups, and studies.
LIMIT Early Adiposity Rebound in Children
Sponsor: University of Pavia
Summary
Childhood obesity is a strong predictor of adult obesity with health and economic consequences for the individual and society. Adiposity rebound (AR) is a rise in the Body Mass Index occurring between 3-7 years. Early adiposity rebound (EAR) occurs at a median age of 2 years and is a risk factor for later obesity. Events happening in "the first 1,000 days" play a role in obesity development. One of the key elements in this crucial time window is the gut microbiome, a highly dynamic organ that is sensitive to environmental exposure being linked to obesity development. Prenatal (dietary/lifestyle maternal factors and environmental exposure) and postnatal determinants (the type of feeding, sleep patterns, speed of growth) and environmental obesogenic pollutants may influence the infant microbial colonization, thus increasing the risk of EAR onset. LIMIT will holistically identify the longitudinal interplay between the intestinal microbiome and infant/maternal nutritional and lifestyle habits, environmental factors exposure and anthropometric measurements, in children with AR vs EAR, driving new mechanistic insights to create an EAR predictive model. The study will evaluate a group of 150 mother-infant pairs, during the first four years of life at different follow-up.
Official title: LIMIT (LIfestyle and Microbiome InTeraction) Early Adiposity Rebound in Children
Key Details
Gender
All
Age Range
1 Day - 48 Months
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2021-12-01
Completion Date
2026-12-31
Last Updated
2021-07-14
Healthy Volunteers
Yes
Interventions
Evaluation of microbiome and maternal/infant lifestyle
Identification of the longitudinal interplay between the intestinal microbiome and infant/maternal nutritional and lifestyle habits, environmental factors exposure and anthropometric measurements, in children with adiposity rebound vs children with early adiposity rebound.